Acceptability and feasibility of medical abortion with mifepristone and misoprostol in Nigeria

被引:16
|
作者
Okonofua, Friday [1 ,2 ]
Shittu, Oladapo [3 ]
Shochet, Tara [4 ]
Diop, Ayisha [4 ]
Winikoff, Beverly [4 ]
机构
[1] Univ Benin, Dept Obstet & Gynaecol, Benin, Nigeria
[2] Womens Hlth & Res Ctr, Benin, Nigeria
[3] Ahmadu Bello Univ, Dept Obstet & Gynecol, Teaching Hosp, Zaria, Nigeria
[4] Gynu Hlth Projects, New York, NY 10010 USA
关键词
Medical abortion; Mifepristone; Misoprostol; Nigeria; HOME; MULTISITE; VIETNAM; SAFETY;
D O I
10.1016/j.ijgo.2013.10.009
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To examine the acceptability and feasibility of medical abortion in Nigeria. Methods: In total, 250 women who were eligible for legal pregnancy termination with a gestational age of up to 63 days since last menstrual period were enrolled in Benin City and Zaria between May 2005 and October 2006. Participants received 200 mg of oral mifepristone in the clinic and then took 400 mu g of oral misoprostol 2 days later-choosing to either return to the clinic or take it at home. Women returned 2 weeks later for an assessment of abortion status. Results: The vast majority (96.3%) of women had successful complete abortions. Ultrasound was used to determine outcome in less than one-third (28.9%) of participants. Most women (83.2%) took the misoprostol at home. Almost all (96.2%) participants were satisfied or very satisfied with the abortion method. Conclusion: The introduction of medical abortion with mifepristone and misoprostol could greatly expand current method options and improve the quality of reproductive health care in Nigeria and other settings in which access to legal abortion services is limited. (C) 2014 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:49 / 52
页数:4
相关论文
共 50 条
  • [21] Risk factors for unsuccessful medical abortion with mifepristone and misoprostol
    Haimov-Kochman, Ronit
    Arbel, Revital
    Sciaky-Tamir, Yael
    Brzezinski, Amnon
    Laufer, Neri
    Yagel, Simcha
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2007, 86 (04) : 462 - 466
  • [22] Mifepristone With Buccal Misoprostol for Medical Abortion A Systematic Review
    Chen, Melissa J.
    Creinin, Mitchell D.
    OBSTETRICS AND GYNECOLOGY, 2015, 126 (01): : 12 - 21
  • [23] Ovulation resumption after medical abortion with mifepristone and misoprostol
    Schreiber, Courtney A.
    Sober, Stephanie
    Ratcliffe, Sarah
    Creinin, Mitchell D.
    CONTRACEPTION, 2011, 84 (03) : 230 - 233
  • [24] Efficacy and acceptability of early mifepristone-misoprostol medical abortion in Ukraine: Results of two clinical trials
    Raghavan, Sheila
    Maistruk, Galina
    Shochet, Tara
    Bannikov, Vladimir
    Posohova, Svetlana
    Zhuk, Svetlana
    Lishchuk, Vladimir
    Winikoff, Beverly
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2013, 18 (02): : 112 - 119
  • [25] Medical abortion with mifepristone and misoprostol at 13-22 weeks: how long between the mifepristone and the misoprostol?
    Abbas, D.
    Ngoc, N.
    Blum, J.
    Nga, N.
    Chi, H.
    Winikoff, B.
    CONTRACEPTION, 2015, 91 (05) : 428 - 428
  • [26] Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: A comparative trial of mifepristone-misoprostol versus surgical abortion
    Winikoff, B
    Sivin, I
    Coyaji, KJ
    Cabezas, E
    Xiao, BL
    Gu, SJ
    Du, MK
    Krishna, UR
    Eschen, A
    Ellertson, C
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1997, 176 (02) : 431 - 437
  • [27] Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial
    Shannon, C.
    Wiebe, E.
    Jacot, F.
    Guilbert, E.
    Dunn, S.
    Sheldon, W. R.
    Winikoff, B.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2006, 113 (06) : 621 - 628
  • [28] Medical abortion with mifepristone and misoprostol: A clinical trial in Taiwanese women
    Tsai, EM
    Yang, CH
    Lee, JN
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2002, 101 (04) : 277 - 282
  • [30] Mifepristone-misoprostol medical abortion: Who will use it and why?
    Blinder, V
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 179 (05) : 1376 - 1376